Aligos Historical Valuation

ALGS Stock  USD 22.99  1.64  7.68%   
Some fundamental drivers such as market cap or Aligos Therapeutics enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Aligos Therapeutics valuation indicators such as Working Capital of 0.0 or Enterprise Value of 273.9 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Aligos Therapeutics's future value.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aligos Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Aligos Stock please use our How to Invest in Aligos Therapeutics guide.

About Aligos Valuation Data Analysis

Valuation is the financial process of determining what Aligos Therapeutics is worth. Aligos Therapeutics valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Aligos Therapeutics valuation ratios help investors to determine whether Aligos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aligos with respect to the benefits of owning Aligos Therapeutics security.

Aligos Therapeutics Valuation Data Chart

Market Cap is likely to drop to about 392.3 M in 2024. Enterprise Value is likely to drop to about 273.9 M in 2024

Enterprise Value

Enterprise Value (or EV) is usually referred to as Aligos Therapeutics theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Aligos Therapeutics debt, but would also pocket its cash. Enterprise Value is more accurate representation of Aligos Therapeutics value than its market capitalization because it takes into account all of Aligos Therapeutics existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Aligos Stock Analysis

When running Aligos Therapeutics' price analysis, check to measure Aligos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aligos Therapeutics is operating at the current time. Most of Aligos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aligos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aligos Therapeutics' price. Additionally, you may evaluate how the addition of Aligos Therapeutics to your portfolios can decrease your overall portfolio volatility.